tm logo
CELLESTIA
Live/Registered
REGISTERED

on 14 Jul 2020

Last Applicant/ Owned by

CH-4057 Basel

CH

Serial Number

79246636 filed on 01st Nov 2018

Registration Number

6098248 registered on 14th Jul 2020

in the Principal Register

Correspondent Address

Anthony E. Bennett

Anthony E. Bennett

6900 JERICHO TURNPIKE SUITE 200

SYOSSET, NY 11791

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CELLESTIA

Pharmaceutical and veterinary products, for the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; pharmaceutical products, namely small molecule drugs for the treatment of cancer; pharmaceut Read More

Classification Information


Class [001]
Chemical Products


Chemical products for use in industry and science, namely, chemicals for use in the manufacture of pharmaceutical and veterinary products; Chemicals for use in biotechnological product development

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary products, for the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; pharmaceutical products, namely small molecule drugs for the treatment of cancer; pharmaceutical products for the treatment of NOTCH-dependent cancers; medicinal preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; veterinary medicines for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; chemical and pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; diagnostic preparations for medical use; chemical and pharmaceutical preparations for veterinary use for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals; research, development of products and quality control in the field of pharmacy; research in the field of chemistry and biology; industrial analysis and research services in the field of pharmaceuticals; research and development of pharmaceutical and veterinary products; chemical analysis and research in the field of pharmaceuticals

Mark Details


Serial Number

No 79246636

Mark Type

No Service Mark

Attorney Docket Number

No 226827IntlUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Nov 2020FINAL DECISION TRANSACTION PROCESSED BY IB
03rd Nov 2020FINAL DISPOSITION PROCESSED
03rd Nov 2020FINAL DISPOSITION NOTICE SENT TO IB
14th Oct 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14th Jul 2020REGISTERED-PRINCIPAL REGISTER
04th Jun 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
15th May 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29th Apr 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29th Apr 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26th Mar 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED